July 19, 2021

What to Know About Johnson & Johnson’s COVID-19 Vaccine and Guillain-Barré Syndrome

7 facts about the FDA’s new warning regarding the one-shot vaccine

vaccine Guillain-Barre

If you received Johnson & Johnson’s COVID-19 vaccine, recent news headlines about its connection to a rare nerve syndrome may have you feeling nervous. But do you need to be?


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The U.S. Food and Drug Administration (FDA) recently issued a warning that the single-dose vaccine is associated with an increased risk of developing Guillain-Barré syndrome (GBS), a rare autoimmune disorder that attacks the body’s nerves.

Here’s what you need to know, as explained by neurologist Kerry Levin, MD.

1. The risk of developing GBS after the COVID-19 vaccine is low

First things first: The likelihood of being diagnosed with GBS after receiving the Johnson & Johnson COVID-19 vaccine is extremely small — about 0.0008%. And Dr. Levin says milder cases of GBS may go undiagnosed, never causing enough concern to warrant a doctor’s visit.

The FDA reports that 12.5 million doses of the Johnson & Johnson vaccine have been administered — about 8% of the population of fully vaccinated people in the United States. As of July 13, 2021 (the day the FDA issued its warning), 100 cases of Guillain-Barré had been reported in individuals who received that vaccine. Of those cases, 95 were considered serious and required hospitalization; one case resulted in death.

The FDA is also careful to point out that although evidence suggests an association between the vaccine and an increased risk of GBS, that evidence is “insufficient to establish a causal relationship.”

2. No other COVID-19 vaccines are associated with the risk of GBS

In the U.S., an estimated 146 million fully vaccinated people have received either the Moderna or Pfizer COVID-19 vaccines (both of which require two doses). To date, the FDA has not seen a statistical increase in GBS in patients who received the Moderna and Pfizer COVID-19 vaccines.

3. GBS symptoms usually develop within two days and start in the extremities

Symptoms of GBS typically develop within 42 days of vaccination, and the first symptom is often numbness or tingling in your hands or feet.

“The typical progression of GBS is from the legs up to the arms over a one-week to four-week period,” Dr. Levin says. “That can be accompanied by progressive heaviness and weakness in the legs the arms — and later on, there can be difficulty with swallowing and breathing, but those are unlikely to be initial presentations.”


Other symptoms of GBS may include:

  • Back pain.
  • Muscle weakness.
  • Heart rate or blood pressure problems.

4. GBS typically develops after an infection, not a vaccine

“It is much more common to get GBS from an infection than from a vaccination,” Dr. Levin explains.

Each year in the U.S., an estimated 3,000 to 6,000 people develop GBS, typically triggered by a viral or bacterial infection, including the flu — or even COVID-19.

That’s right: Dr. Levin says there are examples of people developing GBS immediately following infection with COVID-19.

5. Most people fully recover from GBS

Though symptoms can last weeks or years, most patients recover within several months.

“In general, the prognosis is very good, and we have very effective ways of treating GBS,” Dr. Levin says. “Most people make a complete recovery.”

If you are experiencing symptoms of GBS — especially tingling, numbness or weakness in your arms and legs — see a medical professional for evaluation.

6. Other vaccines have been associated with Guillain-Barré syndrome

Although the Johnson & Johnson shot is the only COVID-19 vaccine that has been linked to Guillain-Barré syndrome, it’s not the first time a vaccine has been linked to the disorder.


In rare cases, people have developed GBS after receiving the flu shot — about one case of GBS for every 1 million influenza vaccines administered. But why?

“There’s evidence that GBS is an autoimmune reaction in which the body produces antibodies directed toward myelin, the insulation of the nerves,” Dr. Levin explains. “Vaccines tend to rev up your immune system, which could rev up antibodies that recognize different tissues within your body as foreign — even though, of course, they are not foreign.”

It’s worth noting that, aside from the flu vaccine, there’s currently no conclusive association between GBS and other vaccines, though it hasn’t been ruled out, either.

7. Doctors still recommend getting the COVID-19 vaccine

Dr. Levin reiterates that the risk of developing Guillain-Barré syndrome after receiving the Johnson & Johnson vaccine is very small, while unvaccinated people’s risk of contracting COVID-19 remains enormously high — especially with variants on the rise.

“The statistics are highly in favor of vaccination,” Dr. Levin says. “If 100 people have developed GBS as a result of 12.8 million people receiving the Johnson & Johnson vaccination, that’s still an extremely small number when compared to the likelihood of getting a serious COVID-19 infection. If you exposed the same number of people to COVID-19, many more than 100 would develop that illness.”

In other words: The prevailing medical recommendation is still that all eligible people should get vaccinated against COVID-19.

Related Articles

female on couch reading a nasal spray bottle label
February 20, 2024
What To Know About Nasal Spray for Migraines

Among the options is a fast-acting medication that offers relief in as little as 15 minutes

two people doing jumping jacks on pavement outside
February 19, 2024
How Exercise Can Help Boost Your Memory

Cardio is great for improving cognition, but strength and balance training are just as important

Caregiver and elderly male with head bent down
February 2, 2024
After Your Stroke: How To Handle 14 Common Complications

Your age, the type of stroke you had, the cause and the location can all impact your recovery

close up of caregiver's hands helping elderly person using a walker
January 2, 2024
Long-Term Care Options for Someone With Alzheimer’s Disease

It’s critical to understand the wishes of your loved one and seek their involvement whenever possible

female caregiver with hand on back of elderly woman in wheelchair
December 25, 2023
How to Care For Someone With Alzheimer’s Disease

Your loved one may need help with daily activities, managing nutritional challenges and adapting their living space

female looking down at smartphone, rubbing back of neck
December 18, 2023
How Your Smartphone May Be Giving You ‘Text Neck’

You can relieve this condition by improving your posture and using a variety of movements

Person holding giant magnifying glass studying giant brain, with machinery
December 12, 2023
Brainwork: The Power of Neuroplasticity

You can build mental muscle by challenging your mind and giving it new experiences

Sad thin elderly adult looking out window.
November 7, 2023
Alzheimer’s Disease and Weight Loss: Why It Happens and What Can Be Done

Finding the causes of weight loss is key to treatment

Trending Topics

glass of cherry juice with cherries on table
Sleepy Girl Mocktail: What’s in It and Does It Really Make You Sleep Better?

This social media sleep hack with tart cherry juice and magnesium could be worth a try

Exercise and diet over three months is hard to accomplish.
Everything You Need To Know About the 75 Hard Challenge

Following five critical rules daily for 75 days may not be sustainable

Person in foreground standing in front of many presents with person in background holding gift bags.
What Is Love Bombing?

This form of psychological and emotional abuse is often disguised as excessive flattery